6IAP

structure of human NKp46 in complex with antibody NKp46-1 and NKp46-4


Sequence Similarity Clusters for the Entities in PDB 6IAP

Entity #1 | Chains: A
Natural cytotoxicity triggering receptor 1 protein, length: 182 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 2 2 48494
95 % 2 2 31903
90 % 2 2 30640
70 % 2 2 36983
50 % 2 2 32054
40 % 22 33 1474
30 % 27 40 1263
Entity #2 | Chains: D
Fab NKp46-4 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 74864
95 % 1 1 61669
90 % 337 594 4
70 % 1591 2557 2
50 % 4051 6625 1
40 % 4052 6626 1
30 % 4081 6673 1
Entity #3 | Chains: E
Fab NKp46-4 heavy chain protein, length: 217 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 74863
95 % 1 1 61668
90 % 1 1 58106
70 % 1940 3169 1
50 % 4052 6625 1
40 % 4053 6626 1
30 % 4082 6673 1
Entity #4 | Chains: H
Fab NKp46-1 heavy chain protein, length: 220 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 74866
95 % 2 2 37321
90 % 2 2 35688
70 % 1941 3169 1
50 % 4053 6625 1
40 % 4054 6626 1
30 % 4083 6673 1
Entity #5 | Chains: L
Fab NKp46-1 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 2 2 48495
95 % 9 10 5894
90 % 338 594 4
70 % 1592 2557 2
50 % 4054 6625 1
40 % 4055 6626 1
30 % 4084 6673 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 6UCF 1 L N123-VRC34_pI4 light chain 9606
17 6UCF 2 H N123-VRC34_pI4 heavy chain 9606
18 5YD4 1 A, C, E, G scFv 4B08 10090
19 5YD3 1 A, C, E, G scFv 4B08 10090
20 6OC7 1 H Heavy chain of HMP42 Fab 9606
21 6OC7 2 L Light chain for HMP42 Fab 9606
22 5UD9 1 H Fab heavy chain 9606
23 5UD9 2 L Light chain 9606
24 4P48 1 A Antibody scFv 180 9031
25 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
26 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
27 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
28 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
29 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
30 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
31 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
32 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
33 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
34 6MEE 2 B, D antibody HEPC74 Light Chain 9606
35 6BJZ 1 H 5c8 Fab Heavy chain 9606
36 6BJZ 2 L 5c8 Fab Light chain 9606
37 6O3D 1 L PGZL1 FAB LIGHT CHAIN 9606
38 6O3D 2 H PGZL1 FAB HEAVY CHAIN 9606
39 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
40 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
41 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
42 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
43 4XCF 1 L 4E10 Fab light chain 9606
44 4XCF 2 H 4E10 Fab heavy chain 9606
45 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
46 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
47 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
48 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
49 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
50 6O24 1 A 4498 Fab heavy chain 9606
51 6O24 2 B 4498 Kappa light chain 9606
52 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
53 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
54 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
55 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
56 6UCE 1 L N123-VRC34_pI3 light chain 9606
57 6UCE 2 H N123-VRC34_pI3 heavy chain 9606
58 5X08 1 H Fab 4E10 Heavy chain 9606
59 5X08 2 L Fab 4E10 Light chain 9606
60 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
61 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
62 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
63 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
64 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
65 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
66 6MEG 1 H antibody HEPC46 Heavy Chain 9606
67 6MEG 2 L antibody HEPC46 Light Chain 9606
68 5C2B 1 H scFv 3B4 9606
69 6O3K 1 L PGZL1.H4K3 light chain 9606
70 6O3K 2 H PGZL1.H4K3 heavy chain 9606
71 4XAW 1 L 4E10 Fab light chain 9606
72 4XAW 2 H 4E10 Fab heavy chain 9606
73 4P49 1 A Antibody scFv B8 9031
74 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
75 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
76 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
77 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
78 6TCR 1 H Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
79 6TCR 2 L Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant 9606
80 5UCB 1 H Fab Heavy Chain 9606
81 5UCB 2 L Fab Light Chain 9606
82 2VXV 1 H HUMAN IGG ABT-325 9606
83 2VXV 2 L HUMAN IGG ABT-325 9606
84 6QF9 1 A, B scFv 9606
85 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
86 4GXV 1 H, I Antibody 1F1, heavy chain 9606
87 4GXV 2 L, M Antibody 1F1, light chain 9606
88 2VXT 1 H MURINE IGG 125-2H 10090
89 2VXT 3 L MURINE IGG 125-2H 10090
90 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
91 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
92 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
93 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
94 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
95 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
96 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
97 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
98 5W24 1 L 5C4 Fab Light Chain 10090
99 5W24 2 H 5C4 Fab Heavy Chain 10090
100 4HPY 1 H CH59 Fab heavy chain 9606
101 4HPY 2 L CH59 Fab light chain 9606
102 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
103 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
104 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
105 4JG1 1 L Fab light chain 9606
106 4JG1 2 H Fab heavy chain 9606
107 6E65 1 L TB31F Fab light chain 9606
108 6E65 2 H TB31F Fab heavy chain 9606
109 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
110 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
111 5VF2 1 A scFv 2D10 10090
112 5I8C 1 A VRC34.01 Fab heavy chain 9606
113 5I8C 2 B VRC34.01 Fab light chain 9606
114 4O5L 1 L Fab F045-092 light chain 9606
115 4O5L 2 H Fab F045-092 heavy chain 9606
116 5MYX 1 A, C Fab c#24 light chain 10090
117 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
118 3IFL 1 L 12A11 FAB antibody light chain 10090
119 3IFL 2 H 12A11 FAB antibody heavy chain 10090
120 5WK2 1 L M116 LIGHT CHAIN 9606
121 5WK2 2 H M116 HEAVY CHAIN FD 9606
122 3PP4 1 H GA101 Fab heavy chain 10090
123 3PP4 2 L GA101 Fab light chain 10090
124 3KDM 1 A, L Immunoglobulin light chain 9606
125 3KDM 2 B, H Immunoglobulin heavy chain 9606
126 5NIV 1 A Light chain of 5D3 Fab 10090
127 5NIV 2 B Heavy chain of 5D3 Fab 10090
128 6UG7 1 L ch28/11 Fab light chain 10090
129 6UG7 2 H ch28/11 Fab heavy chain 10090
130 5N4J 1 L LIGHT CHAIN 9606
131 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
132 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
133 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
134 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
135 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
136 5X4G 1 A 6H8 Fab heavy chain 10090
137 5X4G 2 B 6H8 Fab light chain 10090
138 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
139 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
140 4PTU 1 A Antibody pn132p2C05, light chain 9606
141 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
142 4TPR 1 L If kappa light chain 10090
143 4TPR 2 H Fab heavy chain 10090
144 6HGU 1 A, H anti-APP-tag Fab heavy-chain 10090
145 6HGU 2 B, L anti-APP-tag Fab light-chain anti-APP-tag Fab heavy-chain 10090
146 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
147 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
148 3IFN 1 H 12A11 FAB antibody heavy chain 10090
149 3IFN 2 L 12A11 FAB antibody light chain 10090
150 5U3P 1 H DH511.4 Fab Heavy Chain 9606
151 5U3P 2 L DH511.4 Fab Light Chain 9606
152 6BLA 1 H AMM01 Fab Heavy chain 9606
153 6BLA 2 L AMM01 Fab Light chain 9606
154 4TOY 1 H 35O22 Fab Heavy chain 9606
155 4TOY 2 L 35O22 Fab Light chain 9606
156 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
157 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
158 3NPS 2 B S4 FAB HEAVY CHAIN 9606
159 3NPS 3 C S4 FAB LIGHT CHAIN 9606
160 5I4F 1 A scFv 2D10 10090
161 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
162 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
163 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
164 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
165 5WN9 1 H scFv 2D10 9606
166 4XC3 1 L 4E10 Fab light chain 9606
167 4XC3 2 H 4E10 Fab heavy chain 9606
168 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
169 4M5Y 1 H, I Fab 5J8 heavy chain 9606
170 4M5Y 2 L, M Fab 5J8 light chain 9606
171 4TQE 1 L If kappa light chain 10090
172 4TQE 2 H Fab heavy chain 10090
173 5YY4 1 A scFv 4B08 10090
174 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
175 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
176 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
177 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
178 6Q19 1 L Fab lambda chain 9606
179 6Q19 2 H Fab heavy chain 9606
180 6PDR 1 L antibody vFP25.18 light chain 10090
181 6PDR 2 H antibody vFP25.18 heavy chain 10090
182 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
183 5VSI 2 L CH1/Ckappa Fab light chain 9606
184 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
185 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
186 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
187 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
188 5JXA 1 H VRC03 Heavy chain 9606
189 5JXA 2 L VRC03 Light chain 9606
190 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
191 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
192 6QCU 1 L Light chain 9606
193 6QCU 2 H Heavy chain 9606
194 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
195 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
196 3NTC 1 L Fab light chain 10090
197 3NTC 2 H Fab heavy chain 10090
198 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
199 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
200 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
201 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
202 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
203 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
204 6PBV 1 A, C Fab668 light chain 9606
205 6PBV 2 B, D Fab668 heavy chain 9606
206 6PZG 1 L NA-80 Fab light chain 9606
207 6PZG 2 H NA-80 Fab heavy chain 9606
208 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
209 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
210 6BE3 1 H Fab (F598) Heavy Chain 9606
211 6BE3 2 L Fab (F598) Light Chain 9606
212 4NWU 1 H APE1551 Ab Fab heavy chain 9606
213 4NWU 2 L APE1551 Ab Fab light chain 9606
214 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
215 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
216 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
217 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
218 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
219 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
220 5EWI 1 H VRC38.01 Heavy Chain 9606
221 5EWI 2 L VRC38.01 Light Chain 9606
222 6SVL 1 A, D, G, H, K, O Fab_heavy_chain 9606
223 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
224 5E2W 1 L AT8 LIGHT CHAIN 10090
225 5E2W 2 H AT8 HEAVY CHAIN 10090
226 5MYK 1 A Fab c#17 light chain 10090
227 5MYK 2 B Fab c#17 heavy chain 10090
228 4NZR 1 H PGT135 heavy chain Fab 9606
229 4NZR 2 L PGT135 light chain Fab 9606
230 5MYO 1 A, C Fab c#6 light chain 10090
231 5MYO 2 B, D Fab c#6 heavy chain 10090
232 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
233 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
234 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
235 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
236 5UEL 1 H 354NC102 Fab Heavy Chain 9606
237 5UEL 2 L 354NC102 Fab Light Chain 9606
238 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
239 6WIY 1 H Fab 54-1G05 heavy chain 9606
240 6WIY 2 L Fab 54-1G05 light chain 9606
241 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
242 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
243 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
244 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
245 5E2V 1 L AT8 LIGHT CHAIN 10090
246 5E2V 2 H AT8 HEAVY CHAIN 10090
247 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
248 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
249 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
250 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
251 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
252 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
253 5JUE 1 L light chain of UIC2 Fab 10090
254 5JUE 2 H heavy chain of UIC2 Fab 10090
255 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
256 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
257 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
258 5JR1 1 H 10E8 heavy chain 9606
259 5JR1 2 L 10E8 mature light chain 9606
260 6CA7 1 L PCT64_13C light chain 9606
261 6CA7 2 H PCT64_13C heavy chain 9606
262 5VF6 1 A single chain variable fragment 9031
263 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
264 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
265 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
266 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
267 6K4Z 1 A, B scFv of C6 The fusion protein of expression tags (residues -2-0), the light chain (residues 1-108), linker GGGGSGGGGSGGGGS (residues 501-515), and the heavy chain (residues 1001-1113) 10090
268 6MVL 2 H Antibody Fab fragment heavy chain 9606
269 6MVL 3 L Antibody Fab fragment light chain 9606
270 5OB5 2 H fAb Heavy chain 9606
271 5OB5 3 L fAb Light chain 9606
272 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
273 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
274 5I66 1 A 8B6 antibody, heavy chain 10090
275 5I66 2 B 8B6 antibody, light chain 10090
276 6QBC 1 H Anti-Mcl1 Fab Heavy Chain 9606
277 6QBC 2 L Anti-Mcl1 Fab Light Chain 9606
278 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
279 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
280 6BZY 1 H 22D11 Heavy Chain 10090
281 6BZY 2 L 22D11 Light Chain 10090
282 3QQ9 1 C, L 101F LIGHT CHAIN 10090
283 3QQ9 2 D, H 101F HEAVY CHAIN 10090
284 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
285 5TKK 3 L mouse antibody vFP5.01 light chain 10090
286 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
287 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
288 5W6C 1 H UCA Fab heavy chain 9606
289 5W6C 2 L UCA Fab light chain 9606
290 5I1K 1 L FAB LIGHT CHAIN 9606
291 5I1K 2 H FAB HEAVY CHAIN 9606
292 3OZ9 1 L Fab NC-1 kappa light chain 10090
293 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
294 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
295 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
296 5V7U 1 L CBTAU-22.1 Fab light chain 9606
297 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
298 5UEA 1 A, H Fab Heavy Chain 9606
299 5UEA 3 B, L Fab Light Chain 9606
300 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
301 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
302 6LTG 1 A, C antibody Fab fragment H-chain 10090
303 6LTG 2 B, D antibody Fab fragment L-chain 10090
304 3G5Y 1 A 175 light chain 10090
305 3G5Y 2 B 175 heavy chain 10090
306 5NMV 1 L Fab light chain 10088
307 5NMV 2 H Fab heavy chain 10088
308 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
309 4N8C 2 L, M Light chain of monoclonal antibody 10090
310 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
311 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
312 4HGW 1 A Antibody Fab fragment, light chain 10090
313 4HGW 2 B Antibody Fab fragment, heavy chain 10090
314 1NLB 1 L antibody 19D9D6 light chain 10090
315 1NLB 2 H antibody 19D9D6 heavy chain 10090
316 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
317 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
318 3VFG 1 L 3F8 Light Chain 10090
319 3VFG 2 H 3F8 Heavy Chain 10090
320 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
321 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
322 3QRG 1 L Fab light chain 9606
323 3QRG 2 H Fab heavy chain Fd fragment 9606
324 5M6A 1 A, B, C, D Bence-Jones light chain 9606
325 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
326 4LLY 2 B, D light chain Clambda 9606
327 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
328 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
329 5EZI 1 H Fab c12 heavy chain 9606
330 5EZI 2 L Fab c12 Light chain 9606
331 4K23 1 H anti-uPAR antibody, heavy chain 10090
332 4K23 2 L anti-uPAR antibody, light chain 10090
333 3NCJ 1 L Fab15 Mut8 light chain 9606
334 3NCJ 2 H Fab15 Mut8 heavy chain 9606
335 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
336 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
337 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
338 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
339 5W05 1 L M59 FAB LIGHT CHAIN 10090
340 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
341 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
342 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
343 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
344 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
345 4M61 1 A, C Fab A52 light chain 10090
346 4M61 2 B, D Fab A52 heavy chain 10090
347 5YE3 1 B 2A7D9 VH CH1 chain 10090
348 5YE3 2 A 2A7D9 L chain 10090
349 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
350 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
351 1UM5 1 L Antibody 21H3 L chain 10090
352 1UM5 2 H Antibody 21H3 H chain 10090
353 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
354 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
355 4NWT 1 L APE1531 Ab Fab light chain 9606
356 4NWT 2 H APE1531 Ab Fab heavy chain 9606
357 3WHX 1 A mAb Fab H fragment 10090
358 3WHX 2 B mAb Fab L fragment 10090
359 3NA9 1 L Fab15 light chain 9606
360 3NA9 2 H Fab15 heavy chain 9606
361 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
362 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
363 6RCO 1 A, C R5.004 heavy chain 9606
364 6RCO 2 B, D R5.004 light chain 9606
365 6VBO 1 L DH813 light chain 9606
366 6VBO 2 H DH813 heavy chain 9606
367 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
368 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
369 4LRI 1 A, B MSL-109 Light Chain 9606
370 4LRI 2 C, P MSL-109 Heavy Chain 9606
371 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
372 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
373 4JN2 1 A, L anti dabigatran Fab 10090
374 4JN2 2 B, H anti dabigatran Fab 10090
375 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
376 4XBE 2 H 4E10 Fab heavy chain 9606
377 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
378 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
379 6BE2 1 H Fab (F598) Heavy Chain 9606
380 6BE2 2 L Fab (F598) Light Chain 9606
381 4JFZ 1 L Fab light chain 9606
382 4JFZ 2 H Fab heavy chain 9606
383 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
384 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
385 3WIF 1 A mAb Fab H fragment 10090
386 3WIF 2 B mAb Fab L fragment 10090
387 5U6A 1 A Light Chain 9606
388 5U6A 2 B Heavy Chain 9606
389 6K0Y 1 A Antibody Heavy Chain 9606
390 6K0Y 2 B Antibody Light Chain 9606
391 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
392 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
393 3MBX 1 L X836 LIGHT CHAIN 10090
394 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
395 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
396 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
397 6APC 1 H Epididymis luminal protein 214 9606
398 6APC 2 L IGL@ protein 9606
399 4HHA 1 A Fab KE5 Fab fragment KE5 9606
400 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
401 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
402 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
403 4RGO 2 H 14G8 heavy chain Fab 10090
404 4RGO 3 L 14G8 light chain Fab 10090
405 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
406 5GRY 1 A, G diabody 9606
407 5UEK 2 H Fab 12E Heavy Chain 9606
408 5UEK 3 L Fab 12E Light Chain 9606
409 3NAA 1 L Fab15 Mut5 light chain 9606
410 3NAA 2 H Fab15 Mut5 heavy chain 9606
411 1Q0X 1 L Fab 9B1, light chain 10090
412 1Q0X 2 H Fab 9B1, heavy chain 10090
413 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
414 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
415 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
416 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
417 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
418 5IK3 2 B, D 1E03 Fab fragment light chain 9606
419 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
420 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
421 5XLI 1 a, b FabL 10090
422 5XLI 2 c, d FabH 10090
423 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
424 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
425 6DC4 1 H Fab AM22 Heavy Chain 9606
426 6DC4 2 L Fab AM22 Light Chain 9606
427 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
428 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
429 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
430 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
431 4WUK 1 H CH65 heavy chain 9606
432 4WUK 2 L CH65 light chain 9606
433 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
434 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
435 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
436 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
437 5JOP 1 D, L Fab 14.22 light chain 10090
438 5JOP 2 E, H Fab14.22 heavy chain 10090
439 4HPO 1 H CH58 Fab heavy chain 9606
440 4HPO 2 L CH58 Fab light chain 9606
441 6VLN 1 H 4498 Fab heavy chain 9606
442 6VLN 2 L 4498 Fab light chain 9606
443 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
444 5UKN 2 L DH522UCA Fab fragment light chain 9544
445 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
446 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
447 5IT2 1 H heavy chain 9606
448 5IT2 2 L light chain 9606
449 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
450 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
451 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
452 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
453 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
454 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
455 5KVE 2 L ZV-48 Antibody scFv 10090
456 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
457 5MO3 3 L Fab of monoclonal antibody, light chain 10090
458 6L8T 1 B, D, L Antibody light chain 9606
459 6L8T 2 A, C, H Antibody heavy chain 9606
460 5GZ0 1 A, C FM329 light chain 1383439
461 5GZ0 2 B, D FM329 heavy chain 1383439
462 6DW2 1 A 6078 Fab light chain 9606
463 6DW2 2 B 6078 Fab heavy chain 9606
464 6SS0 1 HHH, III Fab C0021181 heavy chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. 9606
465 6SS0 2 LLL, MMM Fab C0021181 light chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. Residue 10 would not be present in the Kabat scheme, but due to problems with non-continuous numbering in L-peptides, we included it. Therefore, residues 2-10 should be read as 1-9, per Kabat. 9606
466 6MG4 1 A, B JTO light chain 9606
467 6BQB 1 L MGG4 Fab light chain 9606
468 6BQB 2 H MGG4 Fab heavy chain 9606
469 4PUB 1 H DX-2930 HEAVY CHAIN 9606
470 4PUB 2 L DX-2930 LIGHT CHAIN 9606
471 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
472 6B14 2 L Light chain of Fab BL3-6S97N 10090
473 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
474 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
475 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
476 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
477 5GS3 1 A, H diabody protein 9606
478 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
479 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
480 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
481 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
482 5VKD 2 H Fab Heavy Chain 9606
483 5VKD 3 L Fab light chain 9606
484 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
485 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
486 5XHG 1 A, C polypeptide(L) 10090
487 5XHG 2 B, D polypeptide(H) 10090
488 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
489 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
490 3UYR 1 H antibody Fab heavy chain 10090
491 3UYR 2 L antibody Fab light chain 10090
492 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
493 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
494 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
495 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
496 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
497 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
498 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
499 3OAZ 2 K, L Fab 2G12, light chain 9606
500 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
501 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
502 1ZAN 1 L Fab AD11 Light Chain 10116
503 1ZAN 2 H Fab AD11 Heavy Chain 10116
504 6CJK 1 A, C Immunoglobulin Fab light chain 9986
505 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
506 4N0Y 1 H IGH526 Heavy Chain 9606
507 4N0Y 2 L IGH526 Light Chain 9606
508 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
509 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
510 6OTC 2 H sFab H3 heavy chain 32630
511 6OTC 3 L sFab H3 light chain 32630
512 6Q1G 1 L H1244 Fab lambda chain 9606
513 6Q1G 2 H H1244 Fab heavy chain 9606
514 5MTH 1 A, H antibody Fab heavy chain 10090
515 5MTH 2 B, L antibody Fab light chain 10090
516 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
517 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
518 6O26 1 A 3246 Fab heavy chain 9606
519 6O26 2 B 3246 Fab light chain 9606
520 1RZF 1 L Fab E51 light chain 9606
521 1RZF 2 H Fab E51 heavy chain 9606
522 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
523 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
524 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
525 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
526 6WJ0 1 H Fab 54-4H03 heavy chain 9606
527 6WJ0 2 L Fab 54-4H03 light chain 9606
528 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
529 4KTE 2 L GE148 Light Chain Fab 9544
530 5I8O 1 H HMM5 antibody heavy chain 9606
531 5I8O 2 L HMM5 antibody light chain 9606
532 4OUO 1 A anti Bla g 1 scFv 9031
533 4JG0 1 L Fab light chain 9606
534 4JG0 2 H Fab heavy chain 9606
535 6LKT 1 A antibody Fab fragment H chain 10090
536 6LKT 2 B antibody Fab Fragment L-chain 10090
537 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
538 4YGV 2 B, L aDabi-Fab2a light chain 9606
539 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
540 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
541 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
542 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
543 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
544 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
545 3EO0 1 A, C GC-1008 Fab Light Chain 10090
546 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
547 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
548 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
549 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
550 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
551 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
552 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
553 6TCO 1 A, L Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab Leu158Pro light chain mutant 9606
554 6TCO 2 B, H Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
555 4FQI 3 H antibody CR9114 heavy chain Fab 9606
556 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
557 6S5A 2 H anti P329G LALA Fab heavy chain 10090
558 6S5A 3 L anti P329G LALA Fab light chain 10090
559 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
560 4JHA 2 L D25 light chain 9606
561 6SS5 1 HHH Fab C0020187 heavy chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. 9606
562 6SS5 2 LLL Fab C0020187 light chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. Residue 10 would not be present in the Kabat scheme, but due to problems with non-continuous numbering in L-peptides, we included it. Therefore, residues 2-10 should be read as 1-9, per Kabat. 9606
563 6B9Z 1 A Trastuzumab Fab light chain 10090
564 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
565 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
566 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
567 4PTT 1 A Antibody pn132p2C05, light chain 9606
568 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
569 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
570 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
571 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
572 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
573 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
574 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
575 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
576 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
577 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
578 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
579 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
580 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
581 4DGV 1 H HCV1 Heavy Chain Fab 9606
582 4DGV 2 L HCV1 Light Chain 9606
583 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
584 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
585 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
586 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
587 5TH2 1 A, C cetuximab Fab, light chain 10090
588 5TH2 2 B, D cetuximab Fab, heavy chain 10090
589 5I8K 1 L HHH1 Fab Light chain 9606
590 5I8K 2 H HHH1 Fab Heavy chain 9606
591 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
592 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
593 6ULF 1 A 4498 Fab heavy chain 9606
594 6ULF 2 B 4498 Fab light chain 9606
595 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
596 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
597 1YNL 1 L Ig gamma light chain 10090
598 1YNL 2 H Ig gamma heavy chain 10090
599 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
600 5EPM 2 B, F Antibody Fab fragment light chain 10090
601 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
602 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
603 3UMT 1 A scFv heavy chain and light chain 10090
604 6U8D 2 H Heavy chain of Fab HCV2 Heavy chain of Fab HCV2 9606
605 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
606 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
607 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
608 6UC5 1 H Fab397 heavy chain 9606
609 6UC5 2 L Fab397 light chain 9606
610 6PEC 1 L antibody light chain 9544
611 6PEC 2 H antibody heavy chain 9544
612 4NUJ 1 A PGT152 light chain 9606
613 4NUJ 2 B PGT152 heavy chain 9606
614 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
615 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
616 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
617 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
618 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
619 3U2S 2 B, L PG9 light chain 9606
620 6PE7 1 H FAB Heavy Chain 9606
621 6PE7 2 L FAB Light chain 9606
622 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
623 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
624 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
625 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
626 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
627 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
628 4NUG 1 L PGT151 light chain 9606
629 4NUG 2 H PGT151 heavy chain 9606
630 7BZ5 2 H Heavy chain of B38 9606
631 7BZ5 3 L Light chain of B38 9606
632 3IU4 1 H chP3 Fab heavy chain 10090
633 3IU4 2 L chP3 Fab light chain 10090
634 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
635 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
636 6DC8 1 L IgG light chain 10090
637 6DC8 2 H IgG heavy chain 10090
638 6NYQ 1 L 1H3 Fab light chain 10090
639 6NYQ 2 H 1H3 Fab heavy chain 10090
640 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
641 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
642 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
643 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
644 6IAS 1 H Fab NKp46-1 heavy chain 32630
645 6IAS 2 L Fab NKp46-1 light chain 32630
646 1P7K 1 A, L antibody light chain FAB 10090
647 1P7K 2 B, H antibody heavy chain FAB 10090
648 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
649 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
650 3RVV 2 C 4C1 - light chain 10090
651 3RVV 3 D 4C1 - heavy chain 10090
652 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
653 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
654 3P0Y 2 H Fab DL11 heavy chain 9606
655 3P0Y 3 L Fab DL11 light chain 9606
656 4NPY 1 A, L germline PGT121 light chain Fab 9606
657 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
658 6ANA 2 H LL2 Fab Heavy Chain 10090
659 6ANA 3 L LL2 Fab Light Chain 10090
660 5IBU 1 B, L 6652 Light Chain 9606
661 5IBU 2 G, H 6652 Heavy Chain 9606
662 5VPL 2 C 4C1 - LIGHT CHAIN 10090
663 5VPL 3 D 4C1 - HEAVY CHAIN 10090
664 6AOD 1 A FXIa Antibody FAB Light Chain 9606
665 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
666 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
667 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
668 2YPV 2 H FAB 12C1 10090
669 2YPV 3 L FAB 12C1 10090
670 6TCM 1 L Omalizumab Fab Omalizumab Fab light chain 9606
671 6TCM 2 H Omalizumab Fab Omalizumab Fab heavy chain 9606
672 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
673 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
674 4JY5 1 L PGT122 light chain Fab 9606
675 4JY5 2 H PGT122 heavy chain Fab 9606
676 6ELE 1 A, H fAB heavy chain 9606
677 6ELE 2 B, L fAB light chain 9606
678 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
679 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
680 6B5R 1 H CIS42 Fab Heavy chain 9606
681 6B5R 2 L CIS42 Fab Light chain 9606
682 3NAC 1 L Fab15 Mut7 light chain 9606
683 3NAC 2 H Fab15 Mut7 heavy chain 9606
684 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
685 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
686 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
687 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
688 1Q72 1 L Fab M82G2, Light chain 10090
689 1Q72 2 H Fab M82G2, Heavy chain 10090
690 6XCA 1 H C105 Heavy Chain 9606
691 6XCA 2 L C105 Light Chain 9606
692 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
693 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
694 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
695 6MNQ 3 L Ab DH727.2 light chain 9544
696 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
697 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
698 4YHO 1 H aDabi-Fab3 heavy chain 9606
699 4YHO 2 L aDabi-Fab3 light chain 9606
700 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
701 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
702 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
703 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
704 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
705 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
706 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
707 4DGY 1 H HCV1 Heavy Chain Fab 9606
708 4DGY 2 L HCV1 Light Chain 9606
709 5EN2 1 A GD01 heavy chain 10090
710 5EN2 2 B GD01 light chain 10090
711 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
712 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
713 6P4Y 1 H 4A10 Fab heavy chain 10090
714 6P4Y 2 L 4A10 Fab light chain 10090
715 3MXW 2 L 5E1 light chain 9606
716 3MXW 3 H 5E1 heavy chain 9606
717 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
718 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
719 3EO9 1 L Efalizumab Fab fragment, light chain 9606
720 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
721 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
722 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
723 6N35 1 K, L Fab 2G12 light chain 9606
724 6N35 2 H, M Fab 2G12 heavy chain 9606
725 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
726 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
727 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
728 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
729 5WUV 1 L light chain 9606
730 5WUV 2 H heavy chain 9606
731 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
732 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
733 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
734 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
735 4JM4 1 H PGT 135 Heavy Chain Fab 9606
736 4JM4 2 L PGT 135 Light Chain Fab 9606
737 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
738 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
739 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
740 5YE4 2 B, D 1A9D7 L chain 10090
741 6B0G 1 C 1245 Antibody, Light Chain 9606
742 6B0G 2 D 1245 Antibody, Heavy Chain 9606
743 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
744 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
745 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
746 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
747 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
748 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
749 6D0X 1 A 2140 Antibody, heavy chain 9606
750 6D0X 2 B 1210 Antibody, light chain 9606
751 6BE4 1 H Fab (F598) Heavy Chain 9606
752 6BE4 2 L Fab(F598) Light Chain 9606
753 5TPP 1 L DH270.5 Fab heavy chain 9606
754 5TPP 2 H DH270.5 Fab light chain 9606
755 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
756 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
757 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
758 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
759 6P7H 1 B Antibody DF2F-b.04 light chain 9479
760 6P7H 2 A Antibody DF2F-b.04 heavy chain 9479
761 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
762 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
763 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
764 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
765 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
766 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
767 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
768 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
769 5TL5 1 L M2177 LIGHT CHAIN 10090
770 5TL5 2 H M2177 HEAVY CHAIN 10090
771 2FX7 1 L Fab 4E10 Light Chain 9606
772 2FX7 2 H Fab 4E10 Heavy Chain 9606
773 6O39 1 A Antibody F2.I Fab, Light chain 9606
774 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
775 5Y9K 1 L belimumab light chain 9606
776 5Y9K 2 H belimumab heavy chain 9606
777 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
778 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
779 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
780 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
781 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
782 6GLW 3 D, L Fab 1D11 - Light chain 9844
783 3WFH 1 A mAb Fab H fragment 10090
784 3WFH 2 B mAb Fab L fragment 10090
785 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
786 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
787 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
788 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
789 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
790 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
791 6GKU 2 H Fab 6F5 - Heavy Chain 9844
792 6GKU 3 L Fab 6F5 - Light chain 9844
793 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
794 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
795 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
796 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
797 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
798 5HI4 3 D, L CAT-2000 FAB light chain 9606
799 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
800 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
801 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
802 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
803 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
804 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
805 3RVW 2 C 4C1 - light chain 10090
806 3RVW 3 D 4C1 - heavy chain 10090
807 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
808 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
809 5XKU 2 B HNIgGA6 light chain 9606
810 5XKU 3 C HNIgGA6 heavy chain 9606
811 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
812 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
813 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
814 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
815 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
816 5HI5 3 D, L CAT-2000 light chain 9606
817 5JO5 1 A, C, E, H 10E8 gHV 9606
818 5JO5 2 B, D, F, L 10E8 gLV 9606
819 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
820 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
821 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
822 5CCK 2 L Antibody 3BC315 Fab light chain 9606
823 6GXX 1 H FAB 1D9 heavy chain 10090
824 6GXX 2 L FAB 1D9 light chain 10090
825 6JP7 1 H immunoglobulin Fab heavy chain 9606
826 6JP7 2 L immunoglobulin Fab light chain 9606
827 5I76 1 A, C FM318_light_chain 1383439
828 5I76 2 B, D FM318_heavy_cahin 1383439
829 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
830 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
831 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
832 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
833 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
834 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
835 5I18 1 L FAB LIGHT CHAIN 9606
836 5I18 2 H FAB HEAVY CHAIN 9606
837 6QB3 2 X scFv55 9606
838 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
839 4JN1 2 L anti-dabigatran Fab1, light chain 10090
840 6UGS 1 A, H Infliximab (Remicade) Fab Heavy Chain 9606
841 6UGS 2 B, L Infliximab (Remicade) Fab Light Chain 9606
842 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
843 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
844 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
845 4G5Z 2 L canakinumab antibody fragment light chain 9606
846 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
847 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
848 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
849 6SF6 1 A, H COMP-reactive monoclonal antibody 15A Fab fragment, heavy chain 10090
850 6SF6 2 B, L COMP-reactive monoclonal antibody 15A Fab fragment, light chain 10090
851 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
852 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
853 2OK0 2 L Fab ED10 light chain 10090
854 2OK0 3 H Fab ED10 heavy chain 10090
855 6P4C 1 L HyHEL10 Fab light chain 10090
856 6P4C 2 H HyHEL10 Fab heavy chain 10090
857 3SOB 1 L antibody light chain 9606
858 3SOB 3 H antibody heavy chain 9606
859 6UG8 1 L ch28/11 Fab light chain 10090
860 6UG8 2 H ch28/11 Fab heavy chain 10090
861 6B5M 1 H CIS43 Fab Heavy chain 9606
862 6B5M 2 L CIS43 Fab Light chain 9606
863 5AWN 1 H Heavy chain of 3BC176 Fab 9606
864 5AWN 2 L Light chain of 3BC176 Fab 9606
865 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
866 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
867 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
868 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
869 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
870 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
871 5DR5 2 L AbD09097 Fab light chain 9606
872 6MG5 1 A, B Light chain JTO 9606
873 2IH3 1 A FAB Heavy Chain 10090
874 2IH3 2 B FAB Light Chain 10090
875 4KQ3 1 L CNTO3186 light chain Fab 9606
876 4KQ3 2 H CNTO3186 heavy chain Fab 9606
877 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
878 6AQ7 3 L POM6 FAB light CHAIN 10090
879 4JFX 1 A, L Fab light chain 9606
880 4JFX 2 B, H Fab heavy chain 9606
881 3SGE 1 I, L Light Chain 10090
882 3SGE 2 H, J Heavy Chain 10090
883 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
884 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
885 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
886 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
887 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
888 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
889 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
890 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
891 5FHB 1 H Antibody 100 Fab heavy chain 9606
892 5FHB 2 L Antibody 100 Fab light chain 9606
893 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
894 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
895 1JGU 1 L Antibody Light Chain 10090
896 1JGU 2 H Antibody Heavy Chain 10090
897 4I77 1 H Lebrikizumab heavy chain Fab 9606
898 4I77 2 L Lebrikizumab light chain Fab 9606
899 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
900 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
901 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
902 4O4Y 2 H 2095-2 heavy chain 9986
903 5OBF 1 H fAb Heavy chain 10090
904 5OBF 2 L fAb Light chain 10090
905 6QNK 1 A, C FAB light chain 10090
906 6QNK 2 B, D FAB heavy chain 10090
907 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
908 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
909 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
910 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
911 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
912 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
913 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
914 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
915 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
916 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
917 5MHE 1 L Fab-fragment 10090
918 5MHE 2 H Fab-fragment 10090
919 5YFI 1 L Light chain of Fab fragment 10090
920 5YFI 2 H Heavy chain of Fab fragment 10090
921 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
922 4GLR 3 I, K anti-ptau light chain light chain 9031
923 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
924 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
925 6MTR 1 H Antibody VRC43.01 Fab heavy chain 9606
926 6MTR 2 L Antibody VRC43.01 Fab light chain 9606
927 4HJG 1 A Trastuzumab light chain 9606